Bone Sialoprotein Immobilized in Collagen Type I Enhances Angiogenesis In Vitro and In Ovo.
angiogenesis
bone sialoprotein
chick yolk sac membrane assay
osteogenesis
tissue regeneration
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
17 Feb 2023
17 Feb 2023
Historique:
received:
19
12
2022
revised:
24
01
2023
accepted:
14
02
2023
entrez:
28
2
2023
pubmed:
1
3
2023
medline:
1
3
2023
Statut:
epublish
Résumé
Bone fracture healing is a multistep process, including early immunological reactions, osteogenesis, and as a key factor, angiogenesis. Molecules inducing osteogenesis as well as angiogenesis are rare, but hold promise to be employed in bone tissue engineering. It has been demonstrated that the bone sialoprotein (BSP) can induce bone formation when immobilized in collagen type I, but its effect on angiogenesis still has to be characterized in detail. Therefore, the aim of this study was to analyse the effects of BSP immobilized in a collagen type I gel on angiogenesis. First, in vitro analyses with endothelial cells (HUVECs) were performed detecting enhancing effects of BSP on proliferation and gene expression of endothelial markers. A spheroid model was employed confirming these results. Finally, the inducing impact of BSP-collagen on vascular density was proved in a yolk sac membrane assay. Our results demonstrate that BSP is capable of inducing angiogenesis and confirm that collagen type I is the optimal carrier for this protein. Taking into account former results, and literature showing that BSP also induces osteogenesis, one can hypothesize that BSP couples angiogenesis and osteogenesis, making it a promising molecule to be used in bone tissue regeneration.
Identifiants
pubmed: 36850289
pii: polym15041007
doi: 10.3390/polym15041007
pmc: PMC9968013
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : CSRD VA
ID : 1
Pays : United States
Références
Biochemistry. 2008 Sep 23;47(38):10162-70
pubmed: 18729384
Biol Res. 2013;46(4):421-9
pubmed: 24510144
Curr Opin Biotechnol. 2022 Aug;76:102750
pubmed: 35841865
Macromol Biosci. 2013 Apr;13(4):444-54
pubmed: 23359587
Tissue Cell. 2022 Dec;79:101908
pubmed: 36084409
J Biol Chem. 2021 Jan-Jun;296:100436
pubmed: 33610546
Bone. 2010 Feb;46(2):447-52
pubmed: 19761880
Materials (Basel). 2018 Nov 21;11(11):
pubmed: 30469365
J Biomed Mater Res B Appl Biomater. 2022 Apr;110(4):967-983
pubmed: 34793621
PLoS One. 2016 Apr 25;11(4):e0153978
pubmed: 27111551
Tissue Eng. 2004 Sep-Oct;10(9-10):1536-47
pubmed: 15588413
Circ Res. 2000 Apr 28;86(8):885-91
pubmed: 10785511
Cell Biol Int. 2018 Nov;42(11):1474-1483
pubmed: 30136736
World J Stem Cells. 2015 Apr 26;7(3):657-68
pubmed: 25914772
J Cell Physiol. 2006 Aug;208(2):326-35
pubmed: 16642470
J Cell Biol. 1998 Nov 30;143(5):1341-52
pubmed: 9832561
Biomatter. 2012 Jul-Sep;2(3):132-41
pubmed: 23507864
Biomed Mater. 2016 Jun 21;11(3):035020
pubmed: 27327854
PLoS One. 2014 May 09;9(5):e95144
pubmed: 24816232
Int J Oral Maxillofac Surg. 2008 Jul;37(7):634-40
pubmed: 18343095
Int J Bioprint. 2022 Jul 12;8(3):591
pubmed: 36105132
Injury. 2022 Nov;53 Suppl 3:S69-S73
pubmed: 35948509
J Clin Med. 2019 Oct 03;8(10):
pubmed: 31623330
J Biomed Mater Res B Appl Biomater. 2018 Oct;106(7):2565-2575
pubmed: 29316208
Biomaterials. 2008 Nov;29(31):4217-26
pubmed: 18692894
J Biomed Mater Res A. 2022 May;110(5):1077-1089
pubmed: 35025130
Biomacromolecules. 2020 Mar 9;21(3):1126-1135
pubmed: 32003967
Biochemistry. 2008 Jun 3;47(22):5986-95
pubmed: 18465841
Cell Prolif. 2017 Dec;50(6):
pubmed: 28960620
Biomaterials. 2007 Feb;28(4):750-61
pubmed: 17045334
J Mol Graph Model. 2013 Feb;39:108-17
pubmed: 23261880
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109761
pubmed: 31349418
Nat Rev Endocrinol. 2016 Apr;12(4):203-21
pubmed: 26893264
J Biomed Mater Res B Appl Biomater. 2022 Feb;110(2):350-357
pubmed: 34291874
Cells Tissues Organs. 2011;194(2-4):182-7
pubmed: 21597272
Adv Drug Deliv Rev. 2015 Nov 1;94:116-25
pubmed: 25817732
World J Orthop. 2017 Jan 18;8(1):36-41
pubmed: 28144577
Mol Med Rep. 2019 Oct;20(4):3924-3932
pubmed: 31485628
Front Oncol. 2019 Feb 05;9:36
pubmed: 30805306
Exp Cell Res. 2000 Feb 1;254(2):299-308
pubmed: 10640428
Nanotheranostics. 2020 Sep 8;4(4):242-255
pubmed: 32923314
Matrix Biol. 2008 Sep;27(7):600-8
pubmed: 18620053
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Biomed Mater Res A. 2010 Mar 15;92(4):1461-7
pubmed: 19402137
Inflamm Regen. 2017 Jan 18;37:2
pubmed: 29259701
J Biol Chem. 2005 Apr 8;280(14):13487-92
pubmed: 15703183
Eur J Med Res. 2007 Jan 31;12(1):6-12
pubmed: 17363352
J Endocrinol. 2012 Sep;214(3):241-55
pubmed: 22700194
Matrix Biol. 2016 May-Jul;52-54:60-77
pubmed: 26763578
Tissue Eng Part A. 2011 May;17(9-10):1389-99
pubmed: 21247344
Biomed Res Int. 2015;2015:421746
pubmed: 26247020
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
FASEB J. 2015 Jul;29(7):3076-84
pubmed: 25857554
Methods Mol Biol. 2016;1430:167-77
pubmed: 27172953
Eur J Trauma Emerg Surg. 2020 Apr;46(2):277-286
pubmed: 31139842
ACS Appl Mater Interfaces. 2019 Apr 24;11(16):14548-14559
pubmed: 30943004